Click for best price
Thyroid Cancer Diagnostic Market Size, Share 2023
Thyroid cancer is a type of cancer that occurs when abnormal cell begin to grow in thyroid gland, responsible for the excretion of thyroid hormones. It is asymptotic in early stage and progresses with formation of lump in thyroid gland. If diagnosed in early stage it can be treated easily.
This report aims to provide a comprehensive presentation of the global market for Thyroid Cancer Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thyroid Cancer Diagnostic. This report contains market size and forecasts of Thyroid Cancer Diagnostic in global, including the following market information:
Global Thyroid Cancer Diagnostic Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global top five companies in 2022 (%)
The global Thyroid Cancer Diagnostic market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Papillary Carcinoma Segment to Reach $ Million by 2035, with a % CAGR in next six years.
The global key manufacturers of Thyroid Cancer Diagnostic include Abbott, Roche, Thermo Fisher Scientific, Siemens Healthcare GmbH, Bio-Rad Laboratories, General Electric, Koninklijke Philips, Agilent Technologies and Illumina, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Thyroid Cancer Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Thyroid Cancer Diagnostic Market, by Type, 2018-2023, 2024-2035 ($ millions)
Global Thyroid Cancer Diagnostic Market Segment Percentages, by Type, 2022 (%)
Papillary Carcinoma
Follicular Carcinoma
Others
Global Thyroid Cancer Diagnostic Market, by Application, 2018-2023, 2024-2035 ($ millions)
Global Thyroid Cancer Diagnostic Market Segment Percentages, by Application, 2022 (%)
Hospital Laboratories
Cancer Diagnostic Centers
Research Institutes
Others
Global Thyroid Cancer Diagnostic Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions)
Global Thyroid Cancer Diagnostic Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Thyroid Cancer Diagnostic revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Thyroid Cancer Diagnostic revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Roche
Thermo Fisher Scientific
Siemens Healthcare GmbH
Bio-Rad Laboratories
General Electric
Koninklijke Philips
Agilent Technologies
Illumina
Outline of Major Chapters:
Chapter 1: Introduces the definition of Thyroid Cancer Diagnostic, market overview.
Chapter 2: Global Thyroid Cancer Diagnostic market size in revenue.
Chapter 3: Detailed analysis of Thyroid Cancer Diagnostic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Thyroid Cancer Diagnostic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Thyroid Cancer Diagnostic Market, Global Outlook and Forecast 2023-2035 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Thyroid Cancer Diagnostic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Thyroid Cancer Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Thyroid Cancer Diagnostic Overall Market Size
2.1 Global Thyroid Cancer Diagnostic Market Size: 2022 VS 2035
2.2 Global Thyroid Cancer Diagnostic Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Thyroid Cancer Diagnostic Players in Global Market
3.2 Top Global Thyroid Cancer Diagnostic Companies Ranked by Revenue
3.3 Global Thyroid Cancer Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Thyroid Cancer Diagnostic Companies in Global Market, by Revenue in 2022
3.5 Global Companies Thyroid Cancer Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Thyroid Cancer Diagnostic Players in Global Market
3.6.1 List of Global Tier 1 Thyroid Cancer Diagnostic Companies
3.6.2 List of Global Tier 2 and Tier 3 Thyroid Cancer Diagnostic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Thyroid Cancer Diagnostic Market Size Markets, 2022 & 2035
4.1.2 Papillary Carcinoma
4.1.3 Follicular Carcinoma
4.1.4 Others
4.2 By Type - Global Thyroid Cancer Diagnostic Revenue & Forecasts
4.2.1 By Type - Global Thyroid Cancer Diagnostic Revenue, 2018-2023
4.2.2 By Type - Global Thyroid Cancer Diagnostic Revenue, 2024-2035
4.2.3 By Type - Global Thyroid Cancer Diagnostic Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Thyroid Cancer Diagnostic Market Size, 2022 & 2035
5.1.2 Hospital Laboratories
5.1.3 Cancer Diagnostic Centers
5.1.4 Research Institutes
5.1.5 Others
5.2 By Application - Global Thyroid Cancer Diagnostic Revenue & Forecasts
5.2.1 By Application - Global Thyroid Cancer Diagnostic Revenue, 2018-2023
5.2.2 By Application - Global Thyroid Cancer Diagnostic Revenue, 2024-2035
5.2.3 By Application - Global Thyroid Cancer Diagnostic Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Thyroid Cancer Diagnostic Market Size, 2022 & 2035
6.2 By Region - Global Thyroid Cancer Diagnostic Revenue & Forecasts
6.2.1 By Region - Global Thyroid Cancer Diagnostic Revenue, 2018-2023
6.2.2 By Region - Global Thyroid Cancer Diagnostic Revenue, 2024-2035
6.2.3 By Region - Global Thyroid Cancer Diagnostic Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Thyroid Cancer Diagnostic Revenue, 2018-2035
6.3.2 US Thyroid Cancer Diagnostic Market Size, 2018-2035
6.3.3 Canada Thyroid Cancer Diagnostic Market Size, 2018-2035
6.3.4 Mexico Thyroid Cancer Diagnostic Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Thyroid Cancer Diagnostic Revenue, 2018-2035
6.4.2 Germany Thyroid Cancer Diagnostic Market Size, 2018-2035
6.4.3 France Thyroid Cancer Diagnostic Market Size, 2018-2035
6.4.4 U.K. Thyroid Cancer Diagnostic Market Size, 2018-2035
6.4.5 Italy Thyroid Cancer Diagnostic Market Size, 2018-2035
6.4.6 Russia Thyroid Cancer Diagnostic Market Size, 2018-2035
6.4.7 Nordic Countries Thyroid Cancer Diagnostic Market Size, 2018-2035
6.4.8 Benelux Thyroid Cancer Diagnostic Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Thyroid Cancer Diagnostic Revenue, 2018-2035
6.5.2 China Thyroid Cancer Diagnostic Market Size, 2018-2035
6.5.3 Japan Thyroid Cancer Diagnostic Market Size, 2018-2035
6.5.4 South Korea Thyroid Cancer Diagnostic Market Size, 2018-2035
6.5.5 Southeast Asia Thyroid Cancer Diagnostic Market Size, 2018-2035
6.5.6 India Thyroid Cancer Diagnostic Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Thyroid Cancer Diagnostic Revenue, 2018-2035
6.6.2 Brazil Thyroid Cancer Diagnostic Market Size, 2018-2035
6.6.3 Argentina Thyroid Cancer Diagnostic Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Thyroid Cancer Diagnostic Revenue, 2018-2035
6.7.2 Turkey Thyroid Cancer Diagnostic Market Size, 2018-2035
6.7.3 Israel Thyroid Cancer Diagnostic Market Size, 2018-2035
6.7.4 Saudi Arabia Thyroid Cancer Diagnostic Market Size, 2018-2035
6.7.5 UAE Thyroid Cancer Diagnostic Market Size, 2018-2035
7 Thyroid Cancer Diagnostic Companies Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Thyroid Cancer Diagnostic Major Product Offerings
7.1.4 Abbott Thyroid Cancer Diagnostic Revenue in Global Market (2018-2023)
7.1.5 Abbott Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Thyroid Cancer Diagnostic Major Product Offerings
7.2.4 Roche Thyroid Cancer Diagnostic Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Company Summary
7.3.2 Thermo Fisher Scientific Business Overview
7.3.3 Thermo Fisher Scientific Thyroid Cancer Diagnostic Major Product Offerings
7.3.4 Thermo Fisher Scientific Thyroid Cancer Diagnostic Revenue in Global Market (2018-2023)
7.3.5 Thermo Fisher Scientific Key News & Latest Developments
7.4 Siemens Healthcare GmbH
7.4.1 Siemens Healthcare GmbH Company Summary
7.4.2 Siemens Healthcare GmbH Business Overview
7.4.3 Siemens Healthcare GmbH Thyroid Cancer Diagnostic Major Product Offerings
7.4.4 Siemens Healthcare GmbH Thyroid Cancer Diagnostic Revenue in Global Market (2018-2023)
7.4.5 Siemens Healthcare GmbH Key News & Latest Developments
7.5 Bio-Rad Laboratories
7.5.1 Bio-Rad Laboratories Company Summary
7.5.2 Bio-Rad Laboratories Business Overview
7.5.3 Bio-Rad Laboratories Thyroid Cancer Diagnostic Major Product Offerings
7.5.4 Bio-Rad Laboratories Thyroid Cancer Diagnostic Revenue in Global Market (2018-2023)
7.5.5 Bio-Rad Laboratories Key News & Latest Developments
7.6 General Electric
7.6.1 General Electric Company Summary
7.6.2 General Electric Business Overview
7.6.3 General Electric Thyroid Cancer Diagnostic Major Product Offerings
7.6.4 General Electric Thyroid Cancer Diagnostic Revenue in Global Market (2018-2023)
7.6.5 General Electric Key News & Latest Developments
7.7 Koninklijke Philips
7.7.1 Koninklijke Philips Company Summary
7.7.2 Koninklijke Philips Business Overview
7.7.3 Koninklijke Philips Thyroid Cancer Diagnostic Major Product Offerings
7.7.4 Koninklijke Philips Thyroid Cancer Diagnostic Revenue in Global Market (2018-2023)
7.7.5 Koninklijke Philips Key News & Latest Developments
7.8 Agilent Technologies
7.8.1 Agilent Technologies Company Summary
7.8.2 Agilent Technologies Business Overview
7.8.3 Agilent Technologies Thyroid Cancer Diagnostic Major Product Offerings
7.8.4 Agilent Technologies Thyroid Cancer Diagnostic Revenue in Global Market (2018-2023)
7.8.5 Agilent Technologies Key News & Latest Developments
7.9 Illumina
7.9.1 Illumina Company Summary
7.9.2 Illumina Business Overview
7.9.3 Illumina Thyroid Cancer Diagnostic Major Product Offerings
7.9.4 Illumina Thyroid Cancer Diagnostic Revenue in Global Market (2018-2023)
7.9.5 Illumina Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Thyroid Cancer Diagnostic Market Opportunities & Trends in Global Market
Table 2. Thyroid Cancer Diagnostic Market Drivers in Global Market
Table 3. Thyroid Cancer Diagnostic Market Restraints in Global Market
Table 4. Key Players of Thyroid Cancer Diagnostic in Global Market
Table 5. Top Thyroid Cancer Diagnostic Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Thyroid Cancer Diagnostic Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Thyroid Cancer Diagnostic Revenue Share by Companies, 2018-2023
Table 8. Global Companies Thyroid Cancer Diagnostic Product Type
Table 9. List of Global Tier 1 Thyroid Cancer Diagnostic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Thyroid Cancer Diagnostic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Thyroid Cancer Diagnostic Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Thyroid Cancer Diagnostic Revenue in Global (US$, Mn), 2024-2035
Table 14. By Application ? Global Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2022 & 2035
Table 15. By Application - Thyroid Cancer Diagnostic Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Thyroid Cancer Diagnostic Revenue in Global (US$, Mn), 2024-2035
Table 17. By Region ? Global Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2022 & 2035
Table 18. By Region - Global Thyroid Cancer Diagnostic Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Thyroid Cancer Diagnostic Revenue (US$, Mn), 2024-2035
Table 20. By Country - North America Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2024-2035
Table 22. By Country - Europe Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2024-2035
Table 24. By Region - Asia Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2024-2035
Table 26. By Country - South America Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2024-2035
Table 28. By Country - Middle East & Africa Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2024-2035
Table 30. Abbott Company Summary
Table 31. Abbott Thyroid Cancer Diagnostic Product Offerings
Table 32. Abbott Thyroid Cancer Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Thyroid Cancer Diagnostic Product Offerings
Table 36. Roche Thyroid Cancer Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Key News & Latest Developments
Table 38. Thermo Fisher Scientific Company Summary
Table 39. Thermo Fisher Scientific Thyroid Cancer Diagnostic Product Offerings
Table 40. Thermo Fisher Scientific Thyroid Cancer Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 41. Thermo Fisher Scientific Key News & Latest Developments
Table 42. Siemens Healthcare GmbH Company Summary
Table 43. Siemens Healthcare GmbH Thyroid Cancer Diagnostic Product Offerings
Table 44. Siemens Healthcare GmbH Thyroid Cancer Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 45. Siemens Healthcare GmbH Key News & Latest Developments
Table 46. Bio-Rad Laboratories Company Summary
Table 47. Bio-Rad Laboratories Thyroid Cancer Diagnostic Product Offerings
Table 48. Bio-Rad Laboratories Thyroid Cancer Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 49. Bio-Rad Laboratories Key News & Latest Developments
Table 50. General Electric Company Summary
Table 51. General Electric Thyroid Cancer Diagnostic Product Offerings
Table 52. General Electric Thyroid Cancer Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 53. General Electric Key News & Latest Developments
Table 54. Koninklijke Philips Company Summary
Table 55. Koninklijke Philips Thyroid Cancer Diagnostic Product Offerings
Table 56. Koninklijke Philips Thyroid Cancer Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 57. Koninklijke Philips Key News & Latest Developments
Table 58. Agilent Technologies Company Summary
Table 59. Agilent Technologies Thyroid Cancer Diagnostic Product Offerings
Table 60. Agilent Technologies Thyroid Cancer Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 61. Agilent Technologies Key News & Latest Developments
Table 62. Illumina Company Summary
Table 63. Illumina Thyroid Cancer Diagnostic Product Offerings
Table 64. Illumina Thyroid Cancer Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 65. Illumina Key News & Latest Developments
List of Figures
Figure 1. Thyroid Cancer Diagnostic Segment by Type in 2022
Figure 2. Thyroid Cancer Diagnostic Segment by Application in 2022
Figure 3. Global Thyroid Cancer Diagnostic Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Thyroid Cancer Diagnostic Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Thyroid Cancer Diagnostic Revenue, 2018-2035 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Thyroid Cancer Diagnostic Revenue in 2022
Figure 8. By Type - Global Thyroid Cancer Diagnostic Revenue Market Share, 2018-2035
Figure 9. By Application - Global Thyroid Cancer Diagnostic Revenue Market Share, 2018-2035
Figure 10. By Type - Global Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2022 & 2035
Figure 11. By Type - Global Thyroid Cancer Diagnostic Revenue Market Share, 2018-2035
Figure 12. By Application - Global Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2022 & 2035
Figure 13. By Application - Global Thyroid Cancer Diagnostic Revenue Market Share, 2018-2035
Figure 14. By Region - Global Thyroid Cancer Diagnostic Revenue Market Share, 2018-2035
Figure 15. By Country - North America Thyroid Cancer Diagnostic Revenue Market Share, 2018-2035
Figure 16. US Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2035
Figure 17. Canada Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2035
Figure 18. Mexico Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2035
Figure 19. By Country - Europe Thyroid Cancer Diagnostic Revenue Market Share, 2018-2035
Figure 20. Germany Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2035
Figure 21. France Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2035
Figure 22. U.K. Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2035
Figure 23. Italy Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2035
Figure 24. Russia Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2035
Figure 25. Nordic Countries Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2035
Figure 26. Benelux Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2035
Figure 27. By Region - Asia Thyroid Cancer Diagnostic Revenue Market Share, 2018-2035
Figure 28. China Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2035
Figure 29. Japan Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2035
Figure 30. South Korea Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2035
Figure 31. Southeast Asia Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2035
Figure 32. India Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2035
Figure 33. By Country - South America Thyroid Cancer Diagnostic Revenue Market Share, 2018-2035
Figure 34. Brazil Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2035
Figure 35. Argentina Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2035
Figure 36. By Country - Middle East & Africa Thyroid Cancer Diagnostic Revenue Market Share, 2018-2035
Figure 37. Turkey Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2035
Figure 38. Israel Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2035
Figure 39. Saudi Arabia Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2035
Figure 40. UAE Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2018-2035
Figure 41. Abbott Thyroid Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche Thyroid Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Thermo Fisher Scientific Thyroid Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Siemens Healthcare GmbH Thyroid Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bio-Rad Laboratories Thyroid Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. General Electric Thyroid Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Koninklijke Philips Thyroid Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Agilent Technologies Thyroid Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Illumina Thyroid Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
